Vitamin A (VA) and insulin-like growth factors (IGF) are important regulators of a wide range of physiological processes. To investigate the IGF system's involvement in the physiological actions of VA, we examined the effects of VA status on components of the IGF system in rats. Male rats (3-wk-old) fed a VA-deficient diet for 11wk developed VA defi ciency, as confirmed by the depletion of serum retinol and hepatic retinyl palmitate. Rats fed the VA-deficient diet had significantly lower body weight (p<0.05) and lower serum IGF-I concentrations than the rats fed the control diet. The decreases in serum IGF-I levels were accompanied by approximately 40% lower levels of the IGF-I mRNA in the liver and lungs. With respect to the gene expression of other IGF system components, VA deficiency caused a twofold induction of IGF-I receptor (IGF-IR) mRNA in the heart and a twofold reduction in IGFBP-6 mRNA in the lungs, but did not alter the expression of IGF-II, IGFBP-1, IGFBP-3, IGFBP-4 or IGFBP-5 in all tissues examined. When VA-deficient rats received a single injec tion of retinoic acid (2mg/rat), tissue IGF-I and IGF-IR gene expression did not change after 4 or 8h, while the expression of IGF-II, IGFBP-4, and IGFBP-6 mRNAs in some tissues in creased rapidly. These results suggest a possible involvement of the IGF system in mediating the physiological actions of VA, including VA-supported growth, in the rat.
Vitamin A (VA), a class of compounds including retinol, retinoic acid (RA), and other derivatives, is es sential to almost all physiological functions including normal growth, vision, reproduction, embryonic and fetal development, the maintenance of numerous tis sues, and overall survival in many species (1) . The indispensability of VA has become clear based on the results of feeding VA-deficient diets to animals. The lesions of VA deficiency are multiple but can be reversed by VA administration, further illustrating the important role of this vitamin in nearly every aspect of life. The effects of VA are exerted primarily by regulating the ex pression of target genes through specific receptors (RA receptors (RAR) and retinoid X receptors (RXR)) (2) . Therefore, with respect to the effects of VA on normal growth, VA might exert its action by influencing a num ber of biochemical and physiological factors controlling growth and cell differentiation.
Insulin-like growth factors (IGF-I and IGF-II, here -inafter IGFs) are important in regulating the growth and differentiation of a variety of tissues (3, 4) . Both have essential roles in fetal development. IGF-I is of primary importance in terms of nutrient-and hor mone-dependent regulation of postnatal growth. It is produced in the liver, secreted into the circulation, and acts on target tissues in an endocrine fashion (5, 6) . It is also produced in most extra-hepatic tissues and can function as an autocrine and/or paracrine growth stim ulator (5, 6) . The biological actions of IGFs, are medi ated by a family of cell-surface receptors that includes the insulin receptor (InR) and type 1 and type 2 IGF re ceptors (IGF-IR, IGF-IIR, respectively). IGF-I exerts its actions primarily through binding to IGF-IR, and partly through binding to InR (7). Furthermore, the actions of IGFs are modulated by IGF-binding proteins (IGFBPs). IGFBPs bind specifically and with high affinity to IGFs, and have been suggested to act as modulators by either enhancing or inhibiting the activity and bioavailability of IGFs (8).
There is an increasing body of evidence indicating a role for VA in the regulation of gene expression in the IGF system. For example, studies using cell cultures have demonstrated the important effects of RA on the expression of IGFBP genes in many cell lines, including up-regulation or down-regulation, depending on either the cell line or the type of IGFBP (9-13), and on the ex pression of IGF-I and IGF-II genes by causing a transient mRNA increase in osteoblast cell lines (14). In a VA-de ficient system in birds, we found, for the first time in vivo, that the gene expression of the IGF system is greatly affected by VA (15, 16 
RESULTS
Effect of VA deficiency on IGF-I serum levels Rats fed the VA-deficient diet had significantly lower body weight (p<0.05) than those fed the control diet (Fig. 1A) . VA deficiency was confirmed by depleted con centrations of retinol in the serum (<12.6ng/mL, nor mal level being 240.1ng/mL, Fig. 1B ) and retinyl palmitate in the liver (approximately 1% of the value for the control group, data not shown). The VA-deficient rats appeared healthy and did not exhibit infection or neurological signs or symptoms. However, the serum IGF-I concentrations were significantly reduced by VA deficiency, being approximately 60% of the value for the control group (p<0.01) (Fig. 1C) . Effect of VA deficiency on the expression of IGF, IGF-IR, and IGFBP genes Prior to examining the effects of VA deficiency on the gene expression of IGF-I, IGF-II, IGF-IR, and IGFBPs, we investigated the tissue distributions of these genes with a RNase protection assay using 32P-labeled probes of the respective genes and total RNA extracted from various tissues of the control group. As shown in Fig. 2 , the dis tribution patterns were clearly distinct between these genes. For example, IGF-I, IGFBP-I, and IGFBP4 mRNA levels were higher, whereas IGF-II, IGF-IR, and IGFBP-5 mRNA levels were much lower in the liver than in the heart and lungs.
Based on the information in Fig. 2 , we next selected the liver, lungs, heart, and testes to examine the effects of VA deficiency on the expression of these genes. As shown in Fig. 3A , the decrease in the serum IGF-I con centrations induced by VA deficiency (Fig. 1C) was ac companied by a significant decrease in the IGF-I mRNA levels in the liver (60% of the control group, p<0.05), the tissue secreting the largest proportion of serum IGF I. The reduction in IGF-I mRNA levels caused by VA de ficiency was also observed in lung tissue, but not the heart (Fig. 3A) or testes (data not shown). In contrast, VA deficiency caused an increase in IGF-IR mRNA levels (Fig. 3A) . However, this up-regulation was observed only in the heart (approximately 200% of the control group) and not in other selected tissues (Fig. 3 and not shown). With respect to IGF-II gene expression, mRNA levels in any of the selected tissues were not af fected by VA deficiency (Fig. 3A) .
The expression of IGFBP-1, -4, -5, and BP-6 genes in the liver was not affected by VA deficiency (Fig. 3B) . In the lungs, VA deficiency did not alter the IGFBP-4 and IGFBP-5 mRNA levels, but significantly reduced that of IGFBP-6 by 60% (p<0.01) as compared to the control group (Fig. 3B) . With regard to IGFBP-3, the most abundant IGFBP in circulation, its expression in the liver and lungs was reduced to about 60% of the respec tive control values as the result of VA deficiency, but the differences were not significant (p>0.05). In addition, VA deficiency did not affect the expression of these genes in the heart or testes tissues (data not shown).
Effect of VA repletion on the expression of IGF, IGF-IR and IGFBP genes
We next examined whether the increase in IGF-IR mRNA levels and the decrease in those of IGF-I and IGFBP-6 that had been caused by VA deficiency could be restored by an injection of VA. Figure 4 shows the ef fects of treatment with RA on IGF-I and IGF-IR gene ex pression in the tissues of the VA-deficient rats. RA injec tion did not alter the IGF-IR mRNA levels in any of the tissues examined including the heart, whereas IGF-IR mRNA expression was significantly increased by VA de ficiency. RA treatment did not restore the decrease in IGF-I mRNA levels in the liver and lungs caused by VA deficiency, but instead caused a further decrease in the lung IGF-I mRNA level. In contrast, with respect to ex pression of the IGF-II gene, 4h after a single injection of RA, the mRNA levels in the liver increased significantly, by approximately 70% (p<0.05), but not those of the lung (Fig. 4A) , heart or testes tissues (data not shown). Compared with the expression of IGF-I and IGF-IR, IGFBP gene expression was more sensitive to RA treat ment. A single injection of RA to the VA-deficient rats significantly increased the IGFBP-4 mRNA level by ap proximately twofold in the liver and lungs, and by more than threefold in the heart 8h after treatment (Fig. 4B) . A similar induction in the IGFBP-4 mRNA level was also observed in the liver, but not in the lungs or heart 4h after treatment (Fig. 4B) . Moreover, the IGFBP-6 mRNA level in the lungs was significantly induced by treatment with RA 8h after injection, although no change was observed after 4h (Fig. 4B) . However, IGFBP-6 gene expression in the liver and heart (Fig.  4B) , and IGFBP-3 and IGFBP-5 gene expression in all tissues examined (data not shown) were not affected by RA treatment.
To further characterize the inductive effects of RA on the expression of IGF-II, IGFBP-4, and IGFBP-6 tran scripts, we performed an experiment with the VA-suffi cient rats that was similar to that done with the VA-defi cient rats. Regardless of the retinoid status, an injection of RA into the VA-sufficient rats also caused a signifi cant increase in IGF-II and IGFBP-4 mRNA levels in the liver after 4h (p<0.01) (Fig. 5) . In addition, just as in the case of the VA-deficient rats, there was no change in IGFBP-4 expression in the lungs or heart, nor that of IGFBP-3, IGFBP-5, and IGFBP-6 genes in all tissues ex amined, 4h after RA treatment (Fig. 5 and data VA in the gene expression of the IGF system has been well documented in many in vitro systems, but rarely in in vivo systems. In the present study, we used an in vivo system (VA-deficient rats) to investigate the regulation of IGF-I, IGF-II, IGF-IR, and IGFBP gene expression by VA in various tissues. This model system has been use ful in the past for studying the involvement of VA in many situations, and has shown that VA plays essential roles in a number of biological processes and in the reg ulation of many genes (1, (22) (23) (24) . In previous studies, we applied this model to Japanese quail, first revealing that the gene expressions of some members of the IGF system are under the control of VA status in birds (15, 16). The present results also indicate that VA status could influence gene expressions in the IGF system of the rat in a species-specific manner, which will be dis cussed in detail below. Serum IGF-I concentrations and tissue IGF-I mRNA levels in the rat were found to be decreased by VA defi ciency, but were less sensitive to the change in VA status than those observed in Japanese quail (15). In Japanese quail, serum IGF-I concentrations and IGF-I mRNA lev els in both the liver and extra-hepatic tissues are signifi cantly decreased in response to the consumption of a VA-deficient diet for 14d after hatching, which pre cedes the decrease in body weight. In contrast, we have obtained preliminary results suggesting that there is no reduction in either the serum IGF-I nor tissue IGF-I mRNA level in response to feeding 3-wk-old rats a VA deficient diet for 8wk (data not shown), the time at which VA-deficient rats began to exhibit a retardation in growth rate as shown in Fig. 1 . However, feeding the 3-wk-old rats a VA-deficient diet for 11wk significantly decreased both the serum IGF-I concentration and tis sue IGF-I mRNA level (Figs. 1 and 3) . With respect to the extra-hepatic tissues, a decrease in the IGF-I mRNA level caused by VA deficiency has been observed in the lung, heart, and testes tissues of Japanese quail (15). In the case of the VA-deficient rats, however, a decrease in the IGF-I mRNA level was observed only in the lungs, and not in the heart and testes tissues (Fig. 3) .
Differences in the degree of VA depletion between the VA-deficient rat and the VA-deficient Japanese quail may be one possible explanation for these discrepancies. In Japanese quail, serum retinol and hepatic retinyl palmitate concentrations are reduced by more than 80% in response to feeding a VA-deficient diet for 14d, and both are below detectable levels after a 21-d VA-de ficient period (15, 25). In the case of the rats in this study, serum retinol levels were still detected even though the rats received a VA-deficient diet for 11wk (an approximate 95% reduction). Furthermore, the dif ferences in the growth stages between the rat and quail when they were deprived of VA may be another basis for their different responses to the VA status. It is well known that hepatic IGF-I mRNA and serum IGF-I levels increase sharply and remain elevated during rapid growth stages in animals, but then begin to decrease with age. We have reported that, in Japanese quail, the hepatic Icy-I mRNA level rises rapidly during the first 3wk after hatching, when the relative growth rate is the highest (26). A rapid depletion of VA occurs during this period, resulting in severe effects on the serum IGF -I and tissue IGF-I mRNA levels. In contrast, due to the slower diminution of VA, rats might not suffer from se vere VA deficiency in the period of highest growth, re sulting in a much smaller impact of VA deficiency on the expression of the IGF-I gene. In fact, it has been re ported that the reduction in serum IGF-I level in re sponse to dietary protein restriction is age-dependent (27). When female rats are fed a low-protein diet for 7d at different ages, protein restriction causes a dramatic decrease in serum IGF-I in the younger animals, and this effect is progressively attenuated with increasing age. In addition to the two aforementioned possibilities, other unknown factors may also affect this species-spe cific responsiveness to VA status.
Although IGF-II is considered to be predominantly a fetal growth factor, the results presented in Fig. 2 show an abundant expression of this gene in some tissues even after birth. Hormonal regulation of IGF-II gene ex pression has been demonstrated in several instances, but the effects of VA deficiency on IGF-II gene expres sion have not previously been studied in any in vivo sys tem. We therefore also examined the effects of VA defi ciency on the expression of this gene in several tissues, including the liver, lungs, heart, and testes. The results of the present study revealed that IGF-II gene expression in these tissues is not influenced by VA deficiency.
The number of receptors present on target cells deter mines the strength of the IGF signal, and both IGF-I and IGF-II act primarily through the Type I IGF receptor (IGF-IR). It is therefore worth examining how VA deficiency affects IGF-IR mRNA expression in various tissues. Compared to IGF-I gene expression, IGF-IR ex pression is less sensitive to changes in VA nutritional status. IGF-IR mRNA was found to increase only in the heart, and remained unchanged in the liver, lungs, and testes. The lower sensitivity to and the tissue-specificity of regulation by VA deficiency are also present in Japanese quail (15). For example, a 14d feeding of a VA-deficient diet did not affect expression of the IGF-IR gene in any of the tissues examined, although it greatly reduced serum IGF-I and tissue IGF-I mRNA levels in the quail. However, when this diet was given for 21d, IGF-IR mRNA increased in the heart, kidney, and testis, but not in the liver, brain or lungs. Taken together, these results clearly indicate that IGF-IR mRNA expres sion is generally up-regulated by VA deficiency, whereas the serum IGF-I concentrations and tissue IGF-I mRNA levels are down-regulated.
The biological activities of IGFs are mediated by their interaction with large soluble proteins (the IGFBPs), of which there are six known to date. Therefore, to clearly understand the physiological role of IGFs in the actions of VA, it is necessary to examine the effects of VA on IGFBP synthesis. Numerous studies on mammals have been dedicated to elucidating the hormonal and meta bolic regulation mediating IGFBP expression (28). With the exception of IGFBP-1 and IGFBP-2, little informa tion is available regarding the expression of IGFBPs in any in vivo system. We previously reported for the first time that the expression of IGFBP-2 and IGFBP-5 genes in Japanese quail is differently affected by changes in the VA nutritional status. For example, VA deficiency causes a significant decrease in the IGFBP-5 mRNA and IGF-I mRNA levels in many tissues (16), but has a neg ligible effect on IGFBP-2 gene expression. In the present study, we found that rat IGFBPs also respond to VA de pletion in gene and tissue-specific manners (Fig. 3B) . Among the IGFBPs examined, the effects of VA defi ciency were limited to IGFBP-6 mRNA in the lung tis sue, where a significant decrease in expression was ob served. We previously reported that IGFBP-5 expression is very sensitive to the change in VA status in Japanese quail; this expression did not, however, change in the VA-deficient rats in the present study. These results sug gest the existence of a species-specific regulatory mech anism for IGFBP genes in response to VA deficiency, at least in the case of IGFBP-5.
It has been reported that starvation-induced changes in serum IGF-I concentration, hepatic IGF-I mRNA level, and tissue IGF-IR mRNA level can be partly or completely restored to control levels by short-term re feeding. For example, Kita et al. (29) reported that serum IGF-I concentration and hepatic IGF-I gene ex pression are fully restored in chickens within 2h of re feeding after food deprivation. Therefore, in the present study, a single dose of RA was given to the VA-deficient rats to examine the short-term effects of RA on gene ex pression of the IGF system in various tissues. Our find ing of no restoration in IGF-I and IGF-IR mRNA levels is in agreement with our previous report regarding Japanese quail (15). It is therefore not reasonable to postulate that the regulation of genes for IGF-I and IGF -IR by retinoid occurs directly by the binding of retinoid receptors to a RA-responsive element (RARE). In fact, no RARE has ever been reported in the promoter re gions of these genes. In contrast, a single injection of RA was found to rapidly induce IGF-II mRNA expres sion, although the expression of this gene is not altered by VA deficiency. This inductive effect of RA on IGF-II gene expression appears to be specific to the liver. Furthermore, administration of RA to the control (VA -sufficient) rats also rapidly induced IGF-II mRNA ex pression in the liver. Enhanced IGF-II mRNA expression as a result of RA treatment has also been described for osteoblast cell lines (14) and several neuroblastoma cell lines (30) (31) (32) . The mechanisms by which RA acts, or the identification of specific responsive elements that may be involved in regulation, however, remain elusive.
A number of studies have demonstrated the impor tant effects of RA on IGFBP expression in many cell lines including up and down-regulation, which depend on either the cell line or the type of IGFBP (9-13). In an in vivo system used for Japanese quail, we previously found that RA can rapidly induce IGFBP-5 mRNA ex pression (16). The present results indicate that the link between VA and IGFBP genes exists not only in birds, but also in mammals. Of the IGFBPs investigated in this study, RA treatment enhanced the gene expression of IGFBP-4 and IGFBP-6. The induction of IGFBP-4 ex pression appeared in all the tissues examined, while the increase in IGFBP-6 expression was observed only in the lungs, where a decrease in the expression of this gene in response to VA deficiency was observed. However, the rapid induction of IGFBP-5 gene expres sion in response to RA treatment, which is observed in Japanese quail, was not seen in the rat. These results suggest that gene-, tissue-, or species-specific mecha nisms might underlie the expression of IGFBP genes as regulated RA.
As described in the introduction, both the IGF system and VA are important in growth regulation. The pres ent study shows that growth retardation as the result of VA deficiency is accompanied by a change in thth IGF system, such as reductions in the level of serum IGF-I and tissue mRNA contents of IGF-I and IGFBP-6. Furthermore, VA repletion induced the expression of some components of the IGF system. Thus, VA may exert, at least partly, its growth-supportive action by in fluencing the IGF system.
In conclusion, the results presented here clearly indi cate that dietary VA levels modulate serum IGF-I con centration and the gene expression of components of the IGF system in the rat. The reduction in mRNA level or the induction of mRNA expression caused by VA de pletion or repletion, respectively, suggests that alter ations in the IGF system may mediate some part of the physiological actions of VA in the rat.
